MARKET

HOLX

HOLX

Hologic Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

76.19
+0.19
+0.25%
After Hours: 76.19 0 0.00% 16:31 05/26 EDT
OPEN
76.53
PREV CLOSE
76.00
HIGH
76.73
LOW
75.80
VOLUME
3.90M
TURNOVER
0
52 WEEK HIGH
81.04
52 WEEK LOW
60.10
MARKET CAP
19.00B
P/E (TTM)
12.54
1D
5D
1M
3M
1Y
5Y
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks · 1d ago
Hologic Announces European CE Mark for Molecular Assays for Use with Transplant Patients
MARLBOROUGH, Mass., May 25, 2022--Hologic Announces European CE Mark for Molecular Assays for Use with Transplant Patients
Business Wire · 1d ago
Hologic Gets CE Mark for Two Molecular Assays for Transplant Patients
MT Newswires · 1d ago
Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Simply Wall St. · 2d ago
If You Invested $1000 in Hologic a Decade Ago, This is How Much It'd Be Worth Now
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Zacks · 3d ago
Insider Sell: Hologic
MT Newswires · 05/19 17:23
Here's Why Investors Should Retain Hologic (HOLX) Stock for Now
Investors are optimistic about Hologic's (HOLX) better-than-expected results and robust segmental growth.
Zacks · 05/18 16:53
Expert Ratings for Hologic
Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter:
Benzinga · 05/17 15:14
More
No Data
Learn about the latest financial forecast of HOLX. Analyze the recent business situations of Hologic Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

31.25%Strong Buy
31.25%Buy
37.50%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average HOLX stock price target is 79.60 with a high estimate of 88.00 and a low estimate of 70.00.
High88.00
Average79.60
Low70.00
Current 76.19
EPS
Actual
Estimate
0.541.081.632.17
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Institutional Holdings
Institutions: 887
Institutional Holdings: 253.10M
% Owned: 101.49%
Shares Outstanding: 249.38M
TypeInstitutionsShares
Increased
210
10.65M
New
99
2.34M
Decreased
256
13.28M
Sold Out
52
2.79M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.61%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen Macmillan
Chief Financial Officer
Karleen Oberton
Corporate Executive
Sean Daugherty
Corporate Executive
Kevin Thornal
Corporate Executive
Jan Verstreken
Senior Vice President/Director of Human Resources
Elisabeth Hellmann
General Counsel
John Griffin
Lead Director/Independent Director
Sally Crawford
Independent Director
Charles Dockendorff
Independent Director
Scott Garrett
Independent Director
Ludwig Hantson
Independent Director
Amy Mcbride-Wendell
Independent Director
Namal Nawana
Independent Director
Christiana Stamoulis
No Data
No Data
About HOLX
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.

Webull offers kinds of Hologic, Inc. stock information, including NASDAQ:HOLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOLX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HOLX stock methods without spending real money on the virtual paper trading platform.